Incidence and risk factors for severe thrombocytopenia in lymphoma patients receiving chemotherapy.

被引：0
|
作者：
Zhou, Xiao
Teegala, Shyam
Ji, Yuan
Fayad, Luis
Romaguera, Jorge Enrique
Hagemeister, F. B.
Vadhan-Raj, Saroj
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Biostat & Applied Math, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Div Pharma, Houston, TX 77030 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3994
引用
收藏
页码：76B / 76B
页数：1
相关论文
共 50 条
  • [1] Incidence and significant predicting factors for chemotherapy-induced severe thrombocytopenia in lymphoma patients
    Zhou, X.
    Huen, A.
    Teegala, S.
    Ji, Y.
    Fayad, L. E.
    Hagemeister, F. B.
    Vadhan-Raj, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] High incidence of venous thromboembolism in patients with lymphoma receiving chemotherapy: Assessment of risk factors.
    Teegala, Shyam
    Zhou, Xiao
    Huen, Auris
    Fayad, Luis
    Romaguera, Jorge Enrique
    Hagemeister, F. B.
    Vadhan-Raj, Saroj
    BLOOD, 2006, 108 (11) : 105B - 106B
  • [3] Risk factors for neutropenic fever in lymphoma patients receiving chemotherapy
    Teegala, S. R.
    Zhou, X.
    Huen, A.
    Ji, Y.
    Fayad, L. E.
    Romaguera, J. E.
    Vadhan-Raj, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Incidence of diabetes and hyperglycemia among patients receiving glucocorticoids with chemotherapy.
    Zylla, Dylan M.
    Steele, Grant
    Gilmore, Grace
    Davidson, Janet
    Carlson, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [5] Risk factors for severe anemia requiring red blood cell transfusions in lymphoma patients receiving chemotherapy
    Zhou, X.
    Teegala, S. R.
    Huen, A.
    Ji, Y.
    Fayad, L. E.
    Romaguera, J. E.
    Hagemeister, F. B.
    Vadhan-Raj, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] INVESTIGATION OF ORAL MUCOSITIS INCIDENCE AND RISK FACTORS IN PATIENTS RECEIVING CHEMOTHERAPY
    Goktuna, Gizem
    Arslan, Gulsah Gurol
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2023, 7 (02): : 747 - 755
  • [7] Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy
    Marina Curra
    Amanda F. Gabriel
    Maria Beatriz C. Ferreira
    Marco Antonio T. Martins
    André T. Brunetto
    Lauro J. Gregianin
    Manoela Domingues Martins
    Supportive Care in Cancer, 2021, 29 : 6243 - 6251
  • [8] Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy
    Curra, Marina
    Gabriel, Amanda F.
    Ferreira, Maria Beatriz C.
    Martins, Marco Antonio T.
    Brunetto, Andre T.
    Gregianin, Lauro J.
    Martins, Manoela Domingues
    SUPPORTIVE CARE IN CANCER, 2021, 29 (11) : 6243 - 6251
  • [9] Risk of febrile neutropenia among patients receiving CHOP chemotherapy.
    Lyman, GH
    Dale, DC
    Crawford, J
    Stolshek, B
    Carter, W
    Delgado, D
    BLOOD, 2001, 98 (11) : 230B - 231B
  • [10] Risk factors for gastrointestinal perforations in patients with metastatic colorectal cancer receiving bevacizumab plus chemotherapy.
    Sugrue, M.
    Kozloff, M.
    Hainsworth, J.
    Badarinath, S.
    Cohn, A.
    Flynn, P.
    Steis, R.
    Dong, W.
    Sarkar, S.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 154S - 154S
12345